Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC
17
Saved in:
Main Authors: | Huang, Y, Zhao, JJ, Soon, YY, Kee, A, Tay, SH, Aminkeng, F, Ang, Y, Wong, A, Goh, BC, Soo, R |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
ELSEVIER SCIENCE INC
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/245750 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC Patients
by: Huang, Y, et al.
Published: (2023) -
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
by: Ng K.Y.Y., et al.
Published: (2022) -
Immune checkpoint inhibitors in ovarian cancer: where do we stand?
by: Leary, A, et al.
Published: (2021) -
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
by: Huang, Yiqing, et al.
Published: (2023) -
Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
by: Wang, Dongdong, et al.
Published: (2023)